Rethinking Long-Term Management of Inflammatory Dermatoses

Welcome back to another Dermatology Times Between the Lines series. In this episode titled, “Rethinking Long-Term Management of Inflammatory Dermatoses,” the expert faculty discuss the chronic, relapsing nature of inflammatory skin diseases and how advances in our understanding of underlying inflammation have influenced treatment goals. The panel explores commonly encountered inflammatory dermatoses, including atopic dermatitis, psoriasis, and seborrheic dermatitis, and examines how durable disease control has become an increasingly important objective in clinical practice.

Throughout the discussion, the faculty highlight the importance of addressing persistent inflammation to improve long-term outcomes and quality of life, while challenging traditional approaches centered on managing individual flares. They discuss how recent advances in topical therapies have expanded the treatment toolbox, allowing clinicians to better maintain disease control and potentially reduce the cycle of relapse and remission that many patients experience.

The conversation also examines the evolving role of topical corticosteroids, emphasizing their continued value as first-line therapies while recognizing the importance of appropriate stewardship and patient counseling. As newer nonsteroidal topical treatments become available, the panel considers how treatment paradigms are shifting toward more individualized, long-term management strategies designed to support continuous disease control in inflammatory dermatoses.

In the next episode, “Understanding Corticosteroid Risks in Inflammatory Dermatoses,” panelists will continue their discussion on inflammatory dermatoses and examine how cumulative corticosteroid exposure can influence treatment decisions. The panel will explore steroid stewardship, the growing role of steroid-sparing therapies, and practical strategies for simplifying treatment regimens while supporting long-term disease control.